These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 15460561)
41. Biomedical research and the commercialization agenda: a review of main considerations for neuroscience. Caulfield T; Ogbogu U Account Res; 2008; 15(4):303-20. PubMed ID: 18972268 [TBL] [Abstract][Full Text] [Related]
42. Federal funding of human embryonic stem cell research: an institutional examination. Fujikawa R South Calif Law Rev; 2005 May; 78(4):1075-124. PubMed ID: 17340756 [No Abstract] [Full Text] [Related]
43. Stem cell research in California: the game is on. Trounson A; Klein R; Murphy R Cell; 2008 Feb; 132(4):522-4. PubMed ID: 18295567 [TBL] [Abstract][Full Text] [Related]
44. Moving human embryonic stem cells from legislature to lab: remaining legal and ethical questions. Greely HT PLoS Med; 2006 Feb; 3(5):e143. PubMed ID: 16492089 [TBL] [Abstract][Full Text] [Related]
45. Research on human embryos, stem cells and cloning -- one year since the passing of Australian federal legislation: Australia around the world and back again. Magri S E Law; 2003 Dec; 10(4):E7. PubMed ID: 16903024 [No Abstract] [Full Text] [Related]
51. California makes unprecedented commitment to fund stem cell research. Willard LA J Biolaw Bus; 2005; 8(2):47-8. PubMed ID: 16538814 [TBL] [Abstract][Full Text] [Related]
52. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp]. Westerlund L Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544 [No Abstract] [Full Text] [Related]
53. The dilemmas of German bioethics. Brown E New Atlantis; 2004; 5():37-53. PubMed ID: 15586957 [No Abstract] [Full Text] [Related]
54. Senators mull new ways to make stem cells. Regalado A Wall St J (East Ed); 2005 Jul; ():B1,B4. PubMed ID: 16134272 [No Abstract] [Full Text] [Related]
55. State stem cell initiatives. Most state stem cell efforts staying afloat. Holden C Science; 2009 Mar; 323(5922):1660-1. PubMed ID: 19325092 [No Abstract] [Full Text] [Related]
56. Navigating the quagmire: the regulation of human embryonic stem cell research. Jones DG; Towns CR Hum Reprod; 2006 May; 21(5):1113-6. PubMed ID: 16361280 [TBL] [Abstract][Full Text] [Related]
57. Leaders and laggards in the stem cell enterprise. Herrera S Nat Biotechnol; 2005 Jul; 23(7):775-7. PubMed ID: 16003350 [No Abstract] [Full Text] [Related]
58. Stem cells, politics and the progress paradigm. DeBow S; Bubela T; Caulfield T Health Law Rev; 2006; 15(1):50-2. PubMed ID: 17153769 [No Abstract] [Full Text] [Related]
59. Market entry and exit by biotech and device companies funded by venture capital. Burns LR; Housman MG; Robinson CA Health Aff (Millwood); 2009; 28(1):w76-86. PubMed ID: 19049998 [TBL] [Abstract][Full Text] [Related]
60. Australia. Stem cell center looks to recast itself in supporting role. Finkel E Science; 2009 Mar; 323(5921):1552-3. PubMed ID: 19299596 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]